Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets (unaudited)

v3.21.2
Condensed Balance Sheets (unaudited) - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash $ 982,249 $ 150,000
Prepaid expenses 347,674  
Receivable from related party 1,242  
Total current assets 1,331,165 150,000
Cash and marketable securities held in Trust Account 358,817,210  
Deferred offering costs   230,653
Interest receivable on cash and marketable securities held in Trust Account 2,950  
Other long-term assets 114,487  
TOTAL ASSETS 360,265,812 380,653
Current liabilities    
Accounts payable 26,471 34,395
Note payable to related parties   125,000
Payable to related parties 57,390 21
Accrued liabilities 2,312,049 230,333
Other current liabilities 6,016  
Total current liabilities 2,401,926 389,749
Warrant liability 384,881  
Deferred underwriting fee payable 12,558,000  
Total liabilities 15,344,807 389,749
Commitments and contingencies (Note 5)
Common stock subject to possible redemption, 35,880,000 shares as of September 30, 2021, at a redemption value of $10.00 per share 358,814,144  
Stockholders’ deficit    
Preferred stock, par value of $0.0001 per share; 1,000,000 shares authorized; none issued or outstanding
Common stock, par value of $0.0001 per share; 100,000,000 shares authorized; 10,069,600 and 8,952,000 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively [1],[2] 1,007 895
Additional paid-in capital   24,105
Accumulated deficit (13,894,146) (34,096)
Total stockholders’ deficit (13,893,139) (9,096)
TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIT $ 360,265,812 $ 380,653
[1]

December 31, 2020 share amounts have been retroactively adjusted to reflect the 1.2:1 stock split effected on February 8, 2021 (see Note 1).

[2]

The December 31, 2020 share number excludes the 1,170,000 Founder shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the Underwriters.